The Sleep Apnea Devices Market size was estimated to be US$ 6280.09 million in 2023 and is expected to reach US$ 12,987.44 million by 2031; it is estimated to record a CAGR of 7.7% in 2031. The increasing prevalence of respiratory diseases, sedentary lifestyle, increasing aging population (over 60 years), and growing prevalence of chronic disorders is likely to remain key Sleep Apnea Devices Market trends.
Increasing life expectancy across the globe is likely to increase the prevalence of sleep disorders. The study ‘Global Prevalence of Obstructive Sleep Apnea in the Elderly and Related Factors: A Systematic Review and Meta-Analysis Study,’ published in June 2023, aimed to combine data and statistics on the worldwide prevalence of OSA in the elderly population. It combined data from 39 studies with a total sample size of 33,353 people were included. The pooled prevalence of OSA in the elderly population was 35.9% (95% confidence interval: 28.7%-43.8%; I2 = 98.81%). The above-mentioned factor is anticipated to have a positive impact on the growth of the sleep apnea devices market.
The growth of the sleep apnea devices market is attributed to some key driving factors such as the increasing prevalence of respiratory diseases, sedentary lifestyle, increasing aging population (over 60 years), and rising prevalence of chronic disorders. However, leaky masks and trouble in falling asleep are major factors hindering the market growth. Global sleep apnea devices market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the US is the largest market for sleep apnea devices. The growth of the region is attributed to the presence of key market players and rising prevalence of the geriatric population. In addition, continuous product developments are further expected to stimulate the growth of the sleep apnea devices market in North America.
The Asia Pacific region is expected to account for the fastest growth in the sleep apnea devices market. The sleep apnea devices market in the Asia Pacific is likely to witness rapid growth owing to a large population, rising medical tourism, and availability of cost-effective sleep apnea devices. Such a factor is expected to aid the growth of the sleep apnea devices market during the forecast period.
Cardiovascular disease refers to the following 4 entities i.e., coronary artery disease (CAD) which is also referred to as coronary heart disease (CHD), cerebrovascular disease, peripheral artery disease (PAD), and aortic atherosclerosis. According to the National Institute of Health (NIH), an estimated 16.3 million Americans aged 20 and older have CHD, a prevalence of 7 percent. The prevalence for men is 8.3 percent and for women is 6.1 percent. Continuous PAP (CPAP) is the common treatment for patients with moderate to severe OSA (AHI ≥ 15 events/h) in the absence of symptoms, but it is also recommended for the treatment of mild OSA patients (AHI 5-15 events/h) in the presence of EDS or other comorbidities such as obesity, hypertension, and cardiac arrest. This need is likely to drive the sleep apnea devices market during the forecast period.
Obstructive sleep apnea (OSA) is a normal and very common disorder categorized by the upper airway's repetitive, complete, or partial closure. In contrast, sleep is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes significant morbidity, especially in terms of impairment of daytime functioning and the impact this has on quality of life. The recent indication from the controlled trials is proof that oral appliance therapy is very effective in controlling OSA in up to 50.0% of patients, including some patients with more severe forms of OSA. This is associated with a significant improvement in symptoms, including snoring and daytime sleepiness. This evidence is strong for short-term and emerging long-term treatment of OSA with oral appliances. Various companies have developed their products for treating sleep apnea and related accessories. For instance, SomnoDent devices developed by SomnoMed Limited have increased in the previous year, 2016, from 68% to 68.6%, which signifies that the products have achieved the signature line of products. Additionally, SomnoDent Alpha has developed and received FDA approval in September 2016. The Alpha is an instant fit device used in sleep clinics for offering the patient and delivering efficacy data of a continuous open airway therapy (COAT) treatment relating to a specific patient before a device is custom-made for the patient. In February 2024, ResMed launched its AirCurve 11 series which are the bilevel devices that use two levels of support, inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). The AirCurve 11 series is combined with digital tech to help treat sleep apnea. Such technological advancements are estimated to generate attractive growth opportunity for the sleep apnea devices market.
Key segments that contributed to the derivation of the Sleep Apnea Devices Market analysis are diagnostic devices and end user.
The geographic scope of the Sleep Apnea Devices Market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South America/South & Central America.
In terms of revenue, North America dominated the sleep apnea devices market share. The North America sleep apnea devices market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North American sleep apnea devices market. Increasing prevalence of sleep apnea disorders among the American population is one of the key factors increasing the demand for sleep apnea devices, thus driving the growth of North America market. Further, high prevalence of sleep apnea and rising awareness about sleep disorders and its risk factors in the US is likely to drive the US sleep apnea devices market. As per the Centers for Disease Control and Prevention (CDC), around one third of the US Population gets less than required amount of sleep. Additionally, as per the American Sleep Apnea Association, around 22 million Americans suffer from sleep apnea. Thus, the growing prevalence of sleep apnea will likely contribute to the growth of the US sleep apnea devices market size.
The regional trends and factors influencing the Sleep Apnea Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Sleep Apnea Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 6280.09 million |
| Market Size by 2031 | US$ 12987.44 million |
| Global CAGR (2023 - 2031) | 7.7% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Diagnostic Devices
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Sleep Apnea Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Sleep Apnea Devices Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The Sleep Apnea Devices Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for Sleep Apnea Devices and strategies:
The “Sleep Apnea Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas: